The National Environment Agency has warned of a surge in cases of dengue in coming months. In fact, the number of cases reported so far this year is far exceeding those reported in 2018 and 2017!
With that in mind, how are biotech companies positioned to address this crisis at hand? And where can investors find attractive opportunities within this growing landscape? Michelle Martin invites Dr David Foster, CEO and Managing Director, Island Pharmaceuticals to find out more.

Money and Me: Budget 2026, CPF 864% Growth & The AI Property Play
27:38

Influence: Ashish Chordia on the AI-Powered Longevity Revolution
18:34

Market View: AI Scare Trade, STI at 5,000 & When Pop Turns Portfolio
24:36